United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 932,700 | 705,100 | 1,067,500 | 1,005,900 | 1,122,600 |
| Marketable Securities | 324,100 | 222,300 | 143,200 | 109,300 | 33,700 |
| Receivables | 211,100 | 297,100 | 251,800 | 273,900 | 188,000 |
| Inventories | 101,500 | 107,900 | 114,400 | 114,100 | 106,900 |
| Other current assets | 64,200 | 115,500 | 62,300 | 60,500 | 52,900 |
| TOTAL | $1,633,600 | $1,447,900 | $1,639,200 | $1,563,700 | $1,504,100 |
| Non-Current Assets | |||||
| PPE Net | 577,500 | 545,700 | 521,700 | 501,900 | 493,500 |
| Investments And Advances | 414,800 | 502,700 | 338,500 | 216,200 | 144,500 |
| Other Non-Current Assets | 394,300 | 383,100 | 436,600 | 409,700 | 419,200 |
| TOTAL | $1,386,600 | $1,431,500 | $1,296,800 | $1,127,800 | $1,057,200 |
| Total Assets | $3,020,200 | $2,879,400 | $2,936,000 | $2,691,500 | $2,561,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 250,000 | 250,000 | N/A |
| Accounts payable and accrued liabilities | 203,400 | 171,100 | 143,300 | 126,800 | 105,600 |
| Other current liabilities | 115,000 | 273,600 | 396,100 | 462,000 | 322,100 |
| TOTAL | $318,400 | $444,700 | $789,400 | $838,800 | $427,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 250,000 | 250,000 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 82,400 | 82,900 | 76,700 | 76,600 | 68,300 |
| TOTAL | $332,400 | $332,900 | $76,700 | $76,600 | $68,300 |
| Total Liabilities | $650,800 | $777,600 | $866,100 | $915,400 | $496,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,544 | 43,240 | 43,211 | 43,443 | 45,057 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 3,090,100 | 2,845,600 | 2,826,600 | 2,550,300 | 2,606,300 |
| Other shareholders' equity | -21,900 | -19,800 | -17,000 | -16,400 | -17,100 |
| TOTAL | $2,369,400 | $2,101,800 | $2,069,900 | $1,776,100 | $2,065,300 |
| Total Liabilities And Equity | $3,020,200 | $2,879,400 | $2,936,000 | $2,691,500 | $2,561,300 |